SCHEMBL5606506

SCHEMBL5606506

CCCCN1C(=O)C(Nc2ccc3occc3c2)=C(c2ccccc2)S1(=O)=O.COc1ccc(NC2=C(c3ccccc3)S(=O)(=O)N(Cc3ccc(OC(F)F)cc3)C2=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 4/20 0.39
NR1H3 Q13133 4/20 0.39
MAPT P10636 4/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
THRB P10828 1/20 0.34
LMNA P02545 3/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
ACP1 P24666 1/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPK1 P28482 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
P2RX3 P56373 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3488264 0.84 NR1H2 (0.53) NR1H2NR1H3MAPTSMN1; SMN2THRB
SCHEMBL3487497 0.83 CA12 (0.40) NR1H2NR1H3
SCHEMBL3488288 0.82 CA12 (0.41) NR1H2NR1H3MAPTSMN1; SMN2LMNA
SCHEMBL3487222 0.80 NR1H2 (0.44) NR1H2NR1H3MAPTSMN1; SMN2ALDH1A1
SCHEMBL5614062 0.79 NPC1 (0.35) MAPTLMNANPC1P2RX3
SCHEMBL5322871 0.79 MAPT (0.40) NR1H2NR1H3MAPTSMN1; SMN2LMNA
SCHEMBL3488399 0.79 NR1H2 (0.55) NR1H2NR1H3MAPTSMN1; SMN2LMNA
SCHEMBL5606877 0.77 NR1H2 (0.38) NR1H2NR1H3MAPTSMN1; SMN2NPC1
SCHEMBL5614006 0.77
SCHEMBL3487898 0.76 P2RX3 (0.35) NR1H2NR1H3MAPTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838686-A1 DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS AstraZeneca AB (SE) 2007-10-03 EP claimed
WO-2006073363-A1 DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2006-07-13 WO claimed